A study found that a blood test detecting ctDNA after surgery more accurately predicts recurrence and survival in patients with stage 3 colon cancer.

“Exelixis Announces U.S. FDA Accepted the New Drug Application for Zanzalintinib in Combination with an Immune Checkpoint ...

Researchers note that toxin appeared to concentrate its effects within tumour tissue and did not cause any harmful inflammation in mice, such as effects on body weight, functions of vital organs and ...

Colon cancer is one of the most preventable cancers, yet its early symptoms are often overlooked or mistaken for minor ...

Zanzalintinib is an investigational oral agent that inhibits tyrosine kinase receptors associated with cancer growth, including TYRO3, VEGF, MET, AXL, and MER.

It's the top cause of cancer death for men and women combined, a new study says.

Most types of cancer have become less deadly over time in adults younger than age 50 in the U.S. but colon and rectum cancers ...

Experts say they're stunned by how quickly colon cancer has overtaken other deadly cancers, including lung and breast.

Cancer is killing far fewer people in early and mid‑adulthood than it did a generation ago, a public‑health success story ...

FOX21's Loving Living Local speaks with leading experts and a colorectal cancer survivor about how biomarker testing is ...

Researchers in Sweden have identified an unexpected biological mechanism that could influence future cancer treatments. Scientists in Sweden have uncovered an unexpected anti-cancer effect from a ...

Colon cancer deaths among people under 50 have risen roughly 1% each year since 2005, researchers reported Jan. 22 in the ...